- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01629888
A Clinical Study for Evaluating the Safety of Excessive Consumption of a Plant Sterol-enriched Yoghurt Drink
October 7, 2016 updated by: Danone Japan
The purpose of this study is to investigate the safety of consumption of three times the standard dose of a yoghurt drink enriched with 1600 mg of plant sterols.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
48
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Osaka, Japan, 560-0082
- Senri Chuo Ekimae Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- male/female subjects,
- aged 20-65 years old,
- triglycerides (TG) levels under 400 mg/dL,
- total cholesterol plasma level under 240 mg/dL (with half the subjects at entry under 200 mg/dL),
- LDL-cholesterol plasma level under 160 mg/dL (with half the subjects at entry under 120 mg/dL),
- non diabetic and non hypertensive,
- accepting to follow the dietary recommendations advisable for hypercholesterolemic patient (Japan Atherosclerosis Society guidelines),
- effective contraceptive methods used for female subjects,
- having given written consent to take part in the study
Exclusion Criteria:
- subjects with sitosterolemia,
- subjects with 200 ml of blood taken within the past month or 400 ml or more within the past 3 months,
- taking any hypocholesterolemic treatment,
- presenting known allergy or hypersensitivity to plant sterols,
- dairy products and lactose, subject with heavy alcohol intake (> 60g/day),
- receiving systemic treatment or topical treatment likely to interfere with evaluation of the study parameters,
- subjects receiving a transplant or under immunosuppressor treatment,
- receiving treatment for any serious pathology.
for female subject:
- pregnancy,
- breast feeding or
- intention to be pregnant during the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: 1 = Tested product
|
1 = Intervention 1 (3 test products/day)
|
PLACEBO_COMPARATOR: 2 = Control product
|
2 = Intervention 2 (3 control products/day)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2010
Primary Completion (ACTUAL)
April 1, 2010
Study Completion (ACTUAL)
June 1, 2010
Study Registration Dates
First Submitted
June 26, 2012
First Submitted That Met QC Criteria
June 27, 2012
First Posted (ESTIMATE)
June 28, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
October 10, 2016
Last Update Submitted That Met QC Criteria
October 7, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NU336
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on 1- plain low-fat dairy fermented product (drinkable) enriched with plant sterols-esters (1,6g /day equivalent as free sterols).
-
Danone ResearchCompletedMild Hypercholesterolemic SubjectsGermany
-
Danone ResearchCompletedHypercholesterolemiaUnited States
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsItaly
-
Danone JapanCompletedNormal and Mild Hypercholesterolemic SubjectsJapan
-
Danone SpainCompletedHypercholesterolemiaSpain
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsCanada
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsFrance
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsUnited Kingdom